Managing HIV peripheral neuropathy

@article{GonzlezDuarte2007ManagingHP,
  title={Managing HIV peripheral neuropathy},
  author={Alejandra Gonz{\'a}lez-Duarte and Katia Cikurel and David M. Simpson},
  journal={Current HIV/AIDS Reports},
  year={2007},
  volume={4},
  pages={114-118}
}
Peripheral nerve disorders are frequent complications of HIV disease. Distal symmetrical polyneuropathy (DSP) is the most common peripheral nerve disorder associated with HIV and occurs in over one third of infected patients but may occur in up to 67% if asymptomatic patients are included. Risk factors for DSP include increased age, advanced HIV disease, and history of “d-drugs” or other neurotoxic drugs. The primary manifestations of polyneuropathy are slowly progressive numbness and… 
HIV Infection and the PNS
TLDR
HIV is neuroinvasive and neurovirulent, but not necessarily neurotrophic, suggesting that most of the neurotoxicity of HIV infection is indirect and most likely mediated via chemokines, cytokines, or viral proteins released by the infiltrating macrophages.
Distal Sensory Peripheral Neuropathy in HIV: A Case Study
TLDR
The clinical and the educational needs of individuals with HIV and DSP are illustrated.
Unraveling the pathogenesis of HIV peripheral neuropathy: insights from a simian immunodeficiency virus macaque model.
TLDR
A unique simian immunodeficiency virus (SIV)/pigtailed macaque model of HIV-PN that enabled detailed morphologic and functional evaluation of the somatosensory pathway throughout disease progression was developed and demonstrated that SIV induces key pathologic features that closely resemble HIV-induced alterations.
Opioids in the management of HIV-related pain.
TLDR
Recent recommendations regarding acute and chronic opioid treatment of pain and the treatment of opioid dependence in HIV-infected patients are reviewed, and suggestions regarding aberrant behavior in pain treatment are provided.
HIV‐1 viral protein R causes peripheral nervous system injury associated with in vivo neuropathic pain
TLDR
Vpr caused DRG neuronal damage, likely through cytosolic calcium activation and cytokine perturbation, highlighting Vpr's contribution to HIV‐associated peripheral neuropathy and ensuing neuropathic pain.
Traditional Chinese Medicine and Human Immunodeficiency Virus-Associated Neuropathy.
TLDR
Acupuncture and moxibustion offer treatment approaches that can reduce HIV symptoms and/or the side-effects of anti-retroviral therapy and improve patients' quality of life.
Peripheral Neuropathy Due to Tuberculosis
TLDR
The causative link of TB infection with PN is rare with few reported cases, of which one is my own study.
...
...

References

SHOWING 1-10 OF 28 REFERENCES
Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection.
  • D. Simpson, M. Tagliati
  • Medicine, Biology
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association
  • 1995
TLDR
The identification and treatment of peripheral neuropathies associated with use of the nucleoside drugs zalcitabine, didanosine (ddI), and stavudine (d4T) are reviewed.
HIV neuropathy: Insights in the pathology of HIV peripheral nerve disease
TLDR
HIV‐associated neuropathies have become the most frequent neurological disorder associated with HIV infection and the use of skin biopsy has become a useful tool in the evaluation of HIV‐N.
Controlling neuropathic pain in HIV
TLDR
Treatment options for painful HIV neuropathy are reviewed, including experimental agents studied in recent and ongoing clinical trials.
HIV-Associated Neuropathic Pain
TLDR
This work reviews the clinical manifestations, epidemiology, pathophysiology and management strategies for HIV-associated DSP, the most common form of peripheral neuropathy in individuals with HIV infection.
Selected peripheral neuropathies associated with human immunodeficiency virus infection and antiretroviral therapy.
  • D. Simpson
  • Medicine, Biology
    Journal of neurovirology
  • 2002
TLDR
The symmetrical forms of polyneuropathy that occur in association with HIV infection and nucleoside analogue therapy are reviewed along with a discussion of theories of pathogenesis and results of treatment to date.
Predominantly sensory neuropathy in patients with AIDS and AIDS‐related complex
TLDR
Predominantly sensory neuropathy in HIV infection appears to be a distal axonal degeneration primarily involving sensory neurons, and the mechanism is unknown, but the neuropathy is associated with the late manifestations of HIV infection.
HIV neuropathy natural history cohort study
TLDR
In this cohort of advanced HIV infection–infected subjects, distal sensory polyneuropathy was common and relatively stable over 48 weeks, and previously established risk factors, including CD4 cell count, plasma HIV RNA, and use of dideoxynucleoside antiretrovirals were not predictive of the progression of DSP.
HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank.
TLDR
DSP in the Manhattan HIV Brain Bank cohort is not associated with increased viral load or decreased CD4 cell counts in this cross-sectional analysis, and symptoms of DSP in substance users may be altered by central mechanisms of increased or decreased tolerance to sensory disturbance.
...
...